Rising Academic Contributions to Drug Development: Evidence of Vigor or Trauma? | Zendy

Michael S. Kinch | Zendy; Caitlin Horn | Zendy; Zachary Kraft | Zendy; Tyler Schwartz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Rising Academic Contributions to Drug Development: Evidence of Vigor or Trauma?

Author(s) -

Michael S. Kinch,

Caitlin Horn,

Zachary Kraft,

Tyler Schwartz

Publication year - 2020

Publication title -

acs pharmacology and translational science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.271

H-Index - 10

ISSN - 2575-9108

DOI - 10.1021/acsptsci.0c00167

Subject(s) - sign (mathematics) , drug development , drug , medicine , engineering ethics , political science , pharmacology , engineering , mathematical analysis , mathematics

We analyzed therapeutic areas most commonly targeted by academia since 2001, finding a domination of certain oncology and infectious diseases. These findings raise important questions about whether this trend reflects an expanded opportunity arising from academic research or a troubling sign of an industry struggling with the challenges of innovation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research